Chemotherapy News and Research

Latest Chemotherapy News and Research

UAB chemists design microcapsules for guided drug delivery system to target solid tumors

Chemists at the University of Alabama at Birmingham have designed triple-threat cancer-fighting polymer capsules that bring the promise of guided drug delivery closer to preclinical testing.

30 Mar 2017

Combining anticancer drug with antirheumatic produces improved effects against tumors

Scientists at EPFL and NTU have discovered that combining an anticancer drug with an antirheumatic produces improved effects against tumors. The discovery opens a new path for drug-drug synergy.

30 Mar 2017

Researchers aim to examine therapeutic effect of iPS-ML producing interferon-β on liver cancer

All causes of the most common form of liver cancer, hepatocellular carcinoma, are not yet known, but the risk of getting it is increased by hepatitis B or C, cirrhosis, obesity, diabetes, a buildup of iron in the liver, or a family of toxins called aflatoxins produced by fungi on some types of food.

29 Mar 2017

City of Hope researchers to highlight basic cancer research and population studies at AACR meeting

City of Hope, a world-renowned independent research and cancer and diabetes treatment center, will highlight a variety of basic research and population studies at the annual meeting of the American Association for Cancer Research at the Walter E. Washington Convention Center in Washington, D.C., April 1 to 5.

28 Mar 2017

Scientists show p300 protein may stop MDS from developing into leukemia

Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that p300, a protein that increases gene expression by attaching acetyl molecules to DNA, may stop myelodysplastic syndrome (MDS) from developing into acute myeloid leukemia (AML). The study was published in the journal Leukemia.

27 Mar 2017

Study shows how epigenetic randomness helps cancer cells proliferate

In a research effort that merged genetics, physics and information theory, a team at the schools of medicine and engineering at The Johns Hopkins University has added significantly to evidence that large regions of the human genome have built-in variability in reversible epigenetic modifications made to their DNA.

27 Mar 2017

FDA approves new maintenance therapy for recurrent cancers

The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.

27 Mar 2017

New study discloses role of specific proteins in killing fast-duplicating cancer cells

Many cancer patients struggle with the adverse effects of chemotherapy, still the most prescribed cancer treatment. For patients with pancreatic cancer and other aggressive cancers, the forecast is more grim: there is no known effective therapy.

27 Mar 2017

Immunotherapy drug becomes first FDA-approved treatment for metastatic MCC

The U.S. Food and Drug Administration yesterday granted accelerated approval to the checkpoint inhibitor Bavencio (avelumab) for the treatment of patients with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy.

25 Mar 2017

Researchers develop nanoparticle to deliver potential new drug to breast cancer cells

The research, a collaborative project between Queen's University Belfast and Ulster University, began at the Queen's Centre for Cancer Research and Cell Biology in 2014, and was led by Professor Mohamed El-Tanani.

24 Mar 2017

New research reveals surprising culprit involved in self-destruction of axons

In many neurodegenerative conditions — Parkinson's disease, amyotrophic lateral sclerosis (ALS) and peripheral neuropathy among them — an early defect is the loss of axons, the wiring of the nervous system.

24 Mar 2017

Research suggests way to reverse age-related and radiation-induced DNA damage

DNA repair is essential for cell vitality, cell survival and cancer prevention, yet cells' ability to patch up damaged DNA declines with age for reasons not fully understood.

24 Mar 2017

Study identifies potential risks for mothers who are cancer survivors

For young women facing a new cancer diagnosis, fertility preservation can be an important consideration in treatment planning. Now a University of North Carolina Lineberger Comprehensive Cancer Center-led study has identified potential risks for mothers who are cancer survivors -- risks for their newborns' health.

23 Mar 2017

New clinical approach offers hope for patients with aggressive brain cancer

Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas - the most common and aggressive brain tumors - are known to recur and progress within short times from the diagnosis.

23 Mar 2017

FDA grants accelerated approval to new drug for treatment of rare form of skin cancer

The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy.

23 Mar 2017

Researchers identify odorant troenan that can inhibit colorectal cancer growth

Growth of colorectal cancer cells can be inhibited with the odorant troenan. This is reported by the research team headed by Prof Dr Dr Dr habil. Hanns Hatt and Dr Lea Weber from Ruhr-Universität Bochum in the journal "PLOS One".

23 Mar 2017

Machine learning helps researchers uncover cellular control networks

The flow of information between cells in our bodies is exceedingly complex: sensing, signaling, and influencing each other in a constant flow of microscopic engagements. These interactions are critical for life, and when they go awry can lead to the illness and injury.

22 Mar 2017

MindMetre research note highlights exposure of oncology nurses to harmful effects of cytotoxic drugs

Independent research organisation MindMetre, which regularly addresses patient and healthcare worker safety across Europe, has examined evidence from qualitative interviews, clinical research and case studies that harm is being sustained by chemotherapy nurses in UK NHS Trusts as a result of exposure to hazardous cytotoxic drugs.

22 Mar 2017

Dana-Farber and Lifespan enter into strategic alliance to advance cancer treatment and research

Dana-Farber Cancer Institute and Lifespan leadership are creating a strategic alliance to advance cancer treatment and research.

22 Mar 2017

Study identifies potential Achilles heel of kinase-driven cancers

Scientists identify two signaling proteins in cancer cells that make them resistant to chemotherapy, and show that blocking the proteins along with chemotherapy eliminate human leukemia in mouse models.

22 Mar 2017

Chemotherapy News and Research

Latest Chemotherapy News and Research

UAB chemists design microcapsules for guided drug delivery system to target solid tumors

Combining anticancer drug with antirheumatic produces improved effects against tumors

Researchers aim to examine therapeutic effect of iPS-ML producing interferon-β on liver cancer

City of Hope researchers to highlight basic cancer research and population studies at AACR meeting

Scientists show p300 protein may stop MDS from developing into leukemia

Study shows how epigenetic randomness helps cancer cells proliferate

FDA approves new maintenance therapy for recurrent cancers

New study discloses role of specific proteins in killing fast-duplicating cancer cells

Immunotherapy drug becomes first FDA-approved treatment for metastatic MCC

Researchers develop nanoparticle to deliver potential new drug to breast cancer cells

New research reveals surprising culprit involved in self-destruction of axons

Research suggests way to reverse age-related and radiation-induced DNA damage

Study identifies potential risks for mothers who are cancer survivors

New clinical approach offers hope for patients with aggressive brain cancer

FDA grants accelerated approval to new drug for treatment of rare form of skin cancer

Researchers identify odorant troenan that can inhibit colorectal cancer growth

Machine learning helps researchers uncover cellular control networks

MindMetre research note highlights exposure of oncology nurses to harmful effects of cytotoxic drugs

Dana-Farber and Lifespan enter into strategic alliance to advance cancer treatment and research

Study identifies potential Achilles heel of kinase-driven cancers

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in